Breaking News Instant updates and real-time market news.

JNJ

Johnson & Johnson

$138.44

-1.65 (-1.18%)

11:45
07/12/19
07/12
11:45
07/12/19
11:45

DOJ pursuing criminal probe of J&J absestos denials, Bloomberg reports

  • 16

    Jul

  • 09

    Sep

  • 16

    Sep

JNJ Johnson & Johnson
$138.44

-1.65 (-1.18%)

07/11/19
RAJA
07/11/19
NO CHANGE
RAJA
Death of drug rebate rule a win for PBMs and distributors, says Raymond James
After multiple media outlets, including Politico, reported that the Trump Administration has decided to withdraw the drug rebate rule, Raymond James analyst Chris Meekins called the news "a win" for pharmacy benefit managers and drug distributors and "a slight negative" for the pharmaceutical makers. The cost of the proposal to the government was ultimately too high with little guarantee that list prices would go down, said Meekins. However, President Trump hinted something "major" on drug pricing was coming over the next week during his kidney care speech and the analyst thinks the President is planning to move forward with an executive order on pricing. Publicly traded pharmaceutical distributors include McKesson (MCK), Cardinal Health (CAH), Amerisource (ABC) and Patterson (PDCO). Owners of pharmacy benefit managers include CVS Health (CVS), UnitedHealth (UNH), Anthem (ANTM) and Cigna (CI). Publicly traded large cap drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
07/11/19
JEFF
07/11/19
NO CHANGE
Target $40
JEFF
Buy
Australia implants decision a 'big positive' for Establishment, says Jefferies
After Australia's Therapeutic Goods Administration proposed to cancel or suspend use of textured breast implants, concluding that these devices are associated with a higher rate of anaplastic large cell lymphoma, or ALCL, Jefferies analyst Raj Denhoy called the decision a "big positive" for Establishment Labs (ESTA). The decision is still in the proposal stage, but Establishment is the only manufacturer with products approved in Australia that is not on the list, which proposes to ban implants from Allergan (AGN), J&J's (JNJ) Mentor and other manufacturers, according to Denhoy. He keeps a Buy rating and $40 price target on shares of Establishment Labs.
07/12/19
FBCO
07/12/19
INITIATION
Target $156
FBCO
Outperform
Johnson & Johnson assumed with an Outperform at Credit Suisse
Credit Suisse analyst Matt Miksic assumed coverage of Johnson & Johnson with an Outperform rating and $156 price target. In a research note to investors, Miksic cites key drivers to the rating, including continued growth in Immunology, driven by Stelera and Tremfya, sustainable growth in Oncology driven by Imbruvica, Darzelex and Erleada, an "attractive" pipeline of filings in the 2019-2023 timeframe with greater than$1B potential each, and "stable" growth and cash flows in Medical Devices and Consumer.
07/12/19
WELS
07/12/19
NO CHANGE
Target $29
WELS
Outperform
Australia implant ban 'excellent news' for Establishment Labs, says Wells Fargo
Wells Fargo analyst David Maris believes Australia's proposal to ban, suspend or impose strict restrictions on a number of textured implants from Allergan (AGN), Johnson & Johnson (JNJ) and other smaller manufacturers is "excellent news" for Establishment Labs Holdings (ESTA). The move by Australia's regulatory body Therapeutic Goods Administration will help solidify Establishment's reputation for safety as the company's Motiva brand is the only listed company without any restricted brands, Maris tells investors in a research note. Further, Australia is a highly regulated and developed market, so the ban could help shift market share in other geographies outside of the county as well, contends the analyst. Maris reiterates an Outperform rating on Establishment Labs with a $29 priced target. The stock closed yesterday up $1.54 to $22.44.

TODAY'S FREE FLY STORIES

IRDM

Iridium

$24.15

0.43 (1.81%)

07:06
07/23/19
07/23
07:06
07/23/19
07:06
Earnings
Iridium reports Q2 EPS (16c), consensus (19c) »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

PNR

Pentair

$37.59

0.21 (0.56%)

07:06
07/23/19
07/23
07:06
07/23/19
07:06
Earnings
Pentair updates FY19 adjusted EPS view to approx. $2.35 from $2.30-$2.35 »

Consensus is $2.31.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

ZION

Zions Bancorp

$45.16

-0.95 (-2.06%)

07:06
07/23/19
07/23
07:06
07/23/19
07:06
Recommendations
Zions Bancorp analyst commentary  »

Zions Bancorp price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBCP

Home Bancorp

$36.17

0.39 (1.09%)

07:06
07/23/19
07/23
07:06
07/23/19
07:06
Earnings
Home Bancorp reports Q2 EPS 71c, consensus 76c »

The net interest margin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ASTE

Astec

$31.16

0.38 (1.23%)

, VMI

Valmont

$127.99

-1.03 (-0.80%)

07:06
07/23/19
07/23
07:06
07/23/19
07:06
Hot Stocks
Astec appoints Barry Ruffalo as president, CEO »

Astec Industries(ASTE) …

ASTE

Astec

$31.16

0.38 (1.23%)

VMI

Valmont

$127.99

-1.03 (-0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 24

    Jul

UTX

United Technologies

$132.94

0.57 (0.43%)

07:05
07/23/19
07/23
07:05
07/23/19
07:05
Earnings
United Technologies raises FY19 adj. EPS view to $7.90-$8.05 from $7.80-$8.00 »

Consensus $7.97. Narrows…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

DNNGY

Orsted A/S

$0.00

(0.00%)

07:05
07/23/19
07/23
07:05
07/23/19
07:05
Downgrade
Orsted A/S rating change  »

Orsted A/S downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHW

Sherwin-Williams

$454.62

-1.9 (-0.42%)

07:05
07/23/19
07/23
07:05
07/23/19
07:05
Earnings
Sherwin-Williams reaffirms FY19 adj. EPS view $20.40-$21.40, consensus $20.94 »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 01

    Aug

  • 06

    Aug

07:05
07/23/19
07/23
07:05
07/23/19
07:05
General news
FX Update: The dollar has posted fresh highs »

FX Update: The dollar has…

JBLU

JetBlue

$18.96

0.05 (0.26%)

, EADSY

Airbus

$0.00

(0.00%)

07:04
07/23/19
07/23
07:04
07/23/19
07:04
Earnings
JetBlue sees achieving $2.50-$3.00 EPS target for 2020, consensus $2.39 »

JetBlue CEO Robin Hayes…

JBLU

JetBlue

$18.96

0.05 (0.26%)

EADSY

Airbus

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 31

    Jul

TXRH

Texas Roadhouse

07:04
07/23/19
07/23
07:04
07/23/19
07:04
Initiation
Texas Roadhouse initiated  »

Texas Roadhouse initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jul

  • 27

    Aug

  • 28

    Aug

  • 13

    Nov

SZEVY

Suez

$0.00

(0.00%)

07:04
07/23/19
07/23
07:04
07/23/19
07:04
Downgrade
Suez rating change  »

Suez downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$51.25

-0.15 (-0.29%)

07:04
07/23/19
07/23
07:04
07/23/19
07:04
Hot Stocks
Coca-Cola sees FY19 cash from operations at least $8.5B »

Sees FY19 CapEx…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 19

    Sep

ASTE

Astec

$31.16

0.38 (1.23%)

07:04
07/23/19
07/23
07:04
07/23/19
07:04
Earnings
Astec reports Q2 adjusted EPS 36c, consensus 41c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

JBLU

JetBlue

$18.96

0.05 (0.26%)

07:03
07/23/19
07/23
07:03
07/23/19
07:03
Hot Stocks
JetBlue sees FY19 capacity up 5.5%-6.5% »

For the full year 2019,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

KEY

KeyCorp

$17.37

-0.08 (-0.46%)

07:03
07/23/19
07/23
07:03
07/23/19
07:03
Earnings
KeyCorp sees Q3 capacity up 3%-5% y/y »

Capacity is expected to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 29

    Aug

SHW

Sherwin-Williams

$454.62

-1.9 (-0.42%)

07:03
07/23/19
07/23
07:03
07/23/19
07:03
Earnings
Sherwin-Williams sees Q3 net sales up by single digit »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 01

    Aug

  • 06

    Aug

KO

Coca-Cola

$51.25

-0.15 (-0.29%)

07:03
07/23/19
07/23
07:03
07/23/19
07:03
Earnings
Coca-Cola sees FY19 11%-12% growth in cc neutral operating income »

Sees: 11%-12% growth in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 19

    Sep

JBLU

JetBlue

$18.96

0.05 (0.26%)

07:02
07/23/19
07/23
07:02
07/23/19
07:02
Earnings
JetBlue reports Q2 adjusted EPS 60c, consensus 57c »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

SSRM

SSR Mining

$15.80

-0.06 (-0.38%)

07:02
07/23/19
07/23
07:02
07/23/19
07:02
Recommendations
SSR Mining analyst commentary  »

SSR Mining price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Aug

SHW

Sherwin-Williams

$454.62

-1.9 (-0.42%)

07:02
07/23/19
07/23
07:02
07/23/19
07:02
Earnings
Sherwin-Williams reports Q2 EPS $6.57 ex-items, consensus $6.37 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 01

    Aug

  • 06

    Aug

EAT

Brinker

$40.58

0.97 (2.45%)

07:01
07/23/19
07/23
07:01
07/23/19
07:01
Initiation
Brinker initiated  »

Brinker initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PNR

Pentair

$37.59

0.21 (0.56%)

07:01
07/23/19
07/23
07:01
07/23/19
07:01
Earnings
Pentair reports Q2 adjusted EPS 69c, consensus 65c »

Reports Q2 revenue $800M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

SKIS

Peak Resorts

$10.85

5.71 (111.09%)

, MTN

Vail Resorts

$235.48

9.665 (4.28%)

07:01
07/23/19
07/23
07:01
07/23/19
07:01
Downgrade
Peak Resorts, Vail Resorts rating change  »

Peak Resorts downgraded…

SKIS

Peak Resorts

$10.85

5.71 (111.09%)

MTN

Vail Resorts

$235.48

9.665 (4.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KO

Coca-Cola

$51.25

-0.15 (-0.29%)

07:00
07/23/19
07/23
07:00
07/23/19
07:00
Earnings
Coca-Cola sees FY19 5% growth in organic revenues »

FY19 revenue consensus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jul

  • 19

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.